Stocks and Investing Stocks and Investing
Thu, September 19, 2024
Wed, September 18, 2024

Sumant Kulkarni Maintained (zvra) at Strong Buy with Decreased Target to $22 on, Sep 18th, 2024


Published on 2024-10-28 14:19:47 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Decreased Target from $24 to $22 on, Sep 18th, 2024.

Sumant has made no other calls on ZVRA in the last 4 months.



There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024
Contributing Sources